ABEO icon

Abeona Therapeutics
ABEO

Overview Fund Trends Analyst Outlook Journalist POV

40 hedge funds and large institutions have $52.5M invested in Abeona Therapeutics in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0.75% more ownership

Funds ownership: 49.64% → 50.39% (+0.75%)

Holders
40
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$491K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.27M
2
+$3.77M
3
+$2.09M
4
Millennium Management
Millennium Management
New York
+$1.27M
5
Citigroup
Citigroup
New York
+$1.05M

Top Sellers

1
-$3.5M
2
-$860K
3
-$130K
4
Deutsche Bank
Deutsche Bank
Germany
-$64.6K
5
JGC
J. Goldman & Co
New York
-$11.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$47.1K
27
$43.5K
28
$42.1K
29
$19.8K
30
$11.2K
31
$4.47K
32
$3.03K
33
$1.68K
34
$707
35
$243
36
$215
37
$59
38
$55
39
–
40
–
41
–
42
–
43
–
44
–
1
2